The FDA announced a new approach to get critical updates on break points for antibiotics and antifungal drugs to health care professionals.
The agency created a website that will provide direct and timely access to information about when bacterial or fungal infections are likely to respond to a specific drug. This approach is intended to aid health care professionals in making more informed prescribing decisions that will both benefit their patients and prevent the spread of drug-resistant